Disease landscape

Psoriatic Arthritis clinical trials

Get alerts when Psoriatic Arthritis trials change

121 active trials 71 recruiting 19 Phase 3 84 sponsors 18 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-22
Primary completion pushed: 2026-08-28 → 2026-12-31
NCT06382051 Modifying PEST for Psoriatic Arthritis Screening · Novartis Pharmaceuticals
2026-08-07
Enrollment closed, study ongoing
Primary completion pushed: 2026-04-30 → 2026-06-05
Completion pushed: 2026-06-30 → 2027-01-30
NCT06640257 A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis · Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Phase 3
2026-08-28
Trial completed
Primary completion moved earlier: 2026-04 → 2026-03-02
Completion moved earlier: 2026-04 → 2026-03-02
NCT06666452 COMFI - a COMbined Fatigue Intervention · The Danish Center for Expertise in Rheumatology
2026-08-27
Enrolling by invitation only
NCT07188285 Mass Spectrometry-based Immune Profiling in Autoimmune Diseases · Peking University People's Hospital
2026-08-09
Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University → Second Affiliated Hospital, Zhejiang University, School of Medicine
NCT06766552 A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients… · Second Affiliated Hospital, School of Medicine, Zhejiang University
2026-08-11
Recruitment opened
NCT07111494 Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic… · Medical College of Wisconsin · Phase 4
2026-08-22
Trial sites expanded: 8 → 11 locations
Primary completion moved earlier: 2032-11-30 → 2029-10-31
Completion moved earlier: 2032-12-01 → 2031-03-11
NCT06751238 Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of… · Novartis Pharmaceuticals · Phase 1
2026-08-07
Primary completion pushed: 2026-06 → 2026-09
Completion pushed: 2026-07 → 2026-10
NCT05908240 Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or… · University of Pennsylvania
2026-08-04
Trial sites expanded: 16 → 45 locations
NCT07286058 Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis · Takeda · Phase 3
2026-08-11
Trial sites expanded: 46 → 50 locations
NCT07486960 Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015) · Merck Sharp & Dohme LLC · Phase 2
2026-08-13
Completion pushed: 2028-04 → 2029-01
NCT04527380 A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis… · Eli Lilly and Company · Phase 3

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-08-19 NCT07772544 Prevention of Psoriatic Arthritis Inflammation Through Digital Care: A Feasibility… Sociedade Portuguesa de Reumatologia new
2026-08-04 NCT07744191 A Clinical Trial of Antiplatelets in Psoriasis NYU Langone Health new Phase 4
2026-07-22 NCT07718815 HLA B Leader in Patients With Psoriatic Arthritis Centre Hospitalier Universitaire, Amiens new
2026-07-15 NCT07706530 Oral CBP-0276 or Placebo in Adults With Active Psoriatic Arthritis (PsA) Clarent Biopharma, Inc. new Phase 2
2026-06-17 NCT07653009 Transcutaneous Auricular Vagus Nerve Stimulation in Psoriatic Arthritis Marmara University new
2026-06-15 NCT07648836 Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic… Assiut University new

Active trials by phase

Phase 1
6
Phase 2
7
Phase 2/3
1
Phase 3
18
Phase 4
10
Not charted: 79 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 121

NCT IDTitleSponsorStatusUpdated
Phase 4
NCT07111494 Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic… Medical College of Wisconsin Recruiting 2026-08-10
NCT07087912 Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in… University of Sao Paulo General Hospital Recruiting 2026-07-20
NCT06864026 A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in… Eli Lilly and Company Recruiting 2026-06-11
NCT07611747 Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in… Instituto de Investigación Marqués de Valdecilla Recruiting 2026-05-28
NCT06454188 A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients… CARE ARTHRITIS LTD. Recruiting 2026-04-03
NCT07486843 Preventing Structural Damage in Early Psoriatic Arthritis Chinese University of Hong Kong Recruiting 2026-03-23
NCT07160231 REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory… Sint Maartenskliniek Recruiting 2025-09-17
NCT07744191 A Clinical Trial of Antiplatelets in Psoriasis NYU Langone Health Not Yet Recruiting 2026-08-05
NCT07280702 Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease University of Texas Southwestern Medical Center Not Yet Recruiting 2026-04-13
NCT06763783 Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases Region Skane Enrolling by Invitation 2025-01-10
Phase 3
NCT06869551 A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165)… Bristol-Myers Squibb Recruiting 2026-08-19
NCT06671483 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic… Takeda Recruiting 2026-08-11
NCT06671496 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been… Takeda Recruiting 2026-08-11
NCT04804553 Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis Amgen Recruiting 2026-08-06
NCT07286058 Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis Takeda Recruiting 2026-08-03
NCT06100744 A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves… AbbVie Recruiting 2026-07-31
NCT06668181 An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in… UCB Biopharma SRL Recruiting 2026-07-17
NCT05767047 A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or… Amgen Recruiting 2025-12-01
NCT05669833 Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients University of Pennsylvania Recruiting 2025-10-09
NCT07791199 Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study… Bristol-Myers Squibb Not Yet Recruiting 2026-08-27
NCT04527380 A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis… Eli Lilly and Company Active, Not Recruiting 2026-08-12
NCT06640257 A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis Suzhou Suncadia Biopharmaceuticals Co., Ltd. Active, Not Recruiting 2026-08-06
NCT06506916 A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study… UCB Biopharma SRL Active, Not Recruiting 2026-07-17
NCT04908202 A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in… Bristol-Myers Squibb Active, Not Recruiting 2026-04-23
NCT04314531 Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With… Sun Pharmaceutical Industries Limited Active, Not Recruiting 2026-03-10
See all 121 active Psoriatic Arthritis trials with filters →

Top sponsors by active trials in this area

AbbVie (5) · Bristol-Myers Squibb (4) · UCB Biopharma SRL (4) · University of California, San Diego (4) · Diakonhjemmet Hospital (3) · NHS Greater Glasgow and Clyde (3) · Novartis Pharmaceuticals (3) · Takeda (3) · Amgen (2) · Assistance Publique - Hôpitaux de Paris (2)

Get alerts when Psoriatic Arthritis trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free